These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7489977)

  • 1. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan.
    Hayashi H; Sugio K; Matsumata T; Adachi E; Takenaka K; Sugimachi K
    Hepatology; 1995 Dec; 22(6):1702-7. PubMed ID: 7489977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness.
    Hsu HC; Tseng HJ; Lai PL; Lee PH; Peng SY
    Cancer Res; 1993 Oct; 53(19):4691-4. PubMed ID: 8402647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.
    Yano M; Hamatani K; Eguchi H; Hirai Y; MacPhee DG; Sugino K; Dohi K; Itamoto T; Asahara T
    Eur J Cancer; 2007 Apr; 43(6):1092-100. PubMed ID: 17350822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 gene mutation spectrum in hepatocellular carcinoma.
    Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
    Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation.
    Huang LR; Hsu HC
    Cancer Res; 1995 Oct; 55(20):4717-21. PubMed ID: 7553654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
    J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
    Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
    Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma.
    Anzola M; Saiz A; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo MA; Burgos JJ
    J Viral Hepat; 2004 Nov; 11(6):502-10. PubMed ID: 15500550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
    Wang XH; Wang PL
    Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aberrations of tumor suppressor genes in hepatocellular carcinomas].
    Fujimoto Y
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1252-60. PubMed ID: 7868063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Mutations in human hepatocellular carcinomas from Germany.
    Kress S; Jahn UR; Buchmann A; Bannasch P; Schwarz M
    Cancer Res; 1992 Jun; 52(11):3220-3. PubMed ID: 1317262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on p53 gene mutation in hepatocellular carcinoma patients in China].
    Kang G; Fang Z; Volkmann M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):163-5. PubMed ID: 11436649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bcl 10 gene mutation in hepatocellular carcinoma.
    Cheng J; Leng X; Cai S; Cao Z; Cao G; Peng J; Wang S; Du R
    Chin Med J (Engl); 2001 Jul; 114(7):747-51. PubMed ID: 11780342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.